Singapore: Today there is true growth potential in the Asian clinical trials market. Read any market report and this is ...
Singapore: Orient EuroPharma, a specialty pharmaceutical company focused in marketing and commercialization has partnere...
Singapore: Many patients with type 2 diabetes who are new to insulin therapy face the daily challenge of not knowing how...
Singapore: The World Health Organization (WHO) has launched Global Hepatitis Network in Singapore to build capacity and...
Singapore: A*STAR Chief Scientist Professor Sir David Lane has been named the winner of this year's Cancer Research UK L...
Boston: Singapore has emerged as the world's 3rd most biotech innovative country in the annual ranking of countries acco...
How can technology be instrumental and more effective in empowering patients to manage diseases? Technology which can p...
Singapore: Biotechnology supplier company, Sartorius Stedim Biotech, has launched new range of single-use bags, under it...
Singapore: Dr Bruno Reversade from A*STAR's Institute of Medical Biology (IMB) is the first scientist, based outside Eu...
Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-fr...
Healthcare industry is in a period of evolution accelerated by changing demographics and market forces propelled by insu...
Singapore: Alcon, global eye care firm, has launched an ophthalmic pharmaceutical manufacturing facility in Singapore to...
Singapore: About 180 million new hospital beds will be needed over the next decade to meet the rising healthcare demand ...
Singapore: Singapore's Health Sciences Authority has signed a memorandum of understanding (MoU) with the National Univer...
Singapore: A new class of ultrasmall peptides developed by A*Star's Institute of Bioengineering and Nanotechnology (IBN)...
Singapore: Mundipharma Ophthalmology Products has announced an agreement with MSD, known as Merck in the United States a...
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...
Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...
